Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / TOMDF - Todos Medical's Letter of Intent with Provista Diagnostics set to license sepsis diagnostic testing

TOMDF - Todos Medical's Letter of Intent with Provista Diagnostics set to license sepsis diagnostic testing

Todos Medical Ltd

--News Direct--

Todos Medical president and CEO Gerald Commissiong joins Proactive's Natalie Stoberman to discuss news of the company entering a Letter of Intent with Provista Diagnostics to license PCR-based sepsis diagnostic test AcuSept LDT rights From Acumen Diagnostics.

Todos Medical engineers life-saving diagnostic solutions for the early detection of a variety of cancers. The company's state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening technology using peripheral blood analysis that examines cancer's influence on the immune system, looking for biochemical changes in blood mononuclear cells and plasma.

Contact Details

Proactive Investors

+1 347-449-0879

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/todos-medicals-letter-of-intent-with-provista-diagnostics-set-to-license-sepsis-diagnostic-testing-214995662

Stock Information
Company Name: Todos Medical Ltd
Stock Symbol: TOMDF
Market: OTC
Website: todosmedical.com
Menu
TOMDF TOMDF Quote TOMDF Short TOMDF News TOMDF Articles TOMDF Message Board
Get TOMDF Alerts

News, Short Squeeze, Breakout and More Instantly...